BackOrphazyme A/S Overview

Orphazyme A/S Selling, General & Admin

Selling, General & Admin expenses for ORPH.

Quarterly SG&A Expenses

$1492.00
100.01% YoY

As of Jun 30, 2024

Annual SG&A Expenses (TTM)

$12.14M
97.12% YoY

Trailing 12 months ending Jun 30, 2024

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)